Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin crossover study in male youth with autism spectrum disorders
ACTRN12609000368235Phase 3Completed
- Sponsor
- University of Sydney
- Start
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by University of Sydney. Primary endpoint: Performance on emotion recognition. Started Oct 2008; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ACTRN12609000368235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000368235.